2016
DOI: 10.17219/acem/61034
|View full text |Cite
|
Sign up to set email alerts
|

The Activity of JAK/STAT and NF-κB in Patients with Rheumatoid Arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0
2

Year Published

2017
2017
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(13 citation statements)
references
References 22 publications
1
10
0
2
Order By: Relevance
“…Several works have established that nuclear factor NF-κB coordinates expression of inflammatory mediators and enzymes involved in the inflammatory response, including COX-2 41,42 . Furthermore, activation of this nuclear factor in the synovial membrane cells of patients with rheumatoid arthritis 43,44 and expression of NF-κB www.nature.com/scientificreports www.nature.com/scientificreports/ p50 and p65 subunits in FLSs under inflammatory stimulus have been reported 45,46 . Our findings that TPCK and SN50, the inhibitors of IK-B phosphorylation and NF-κB translocation and activation, respectively, prevented BaP1-induced expression of COX-2 indicate that activation of NF-κB is a key mechanism by which this metalloprotease triggers COX-2 gene and protein expression and PGE 2 synthesis in FLSs.…”
Section: Discussionmentioning
confidence: 99%
“…Several works have established that nuclear factor NF-κB coordinates expression of inflammatory mediators and enzymes involved in the inflammatory response, including COX-2 41,42 . Furthermore, activation of this nuclear factor in the synovial membrane cells of patients with rheumatoid arthritis 43,44 and expression of NF-κB www.nature.com/scientificreports www.nature.com/scientificreports/ p50 and p65 subunits in FLSs under inflammatory stimulus have been reported 45,46 . Our findings that TPCK and SN50, the inhibitors of IK-B phosphorylation and NF-κB translocation and activation, respectively, prevented BaP1-induced expression of COX-2 indicate that activation of NF-κB is a key mechanism by which this metalloprotease triggers COX-2 gene and protein expression and PGE 2 synthesis in FLSs.…”
Section: Discussionmentioning
confidence: 99%
“…The pathophysiology of rheumatoid arthritis (RA) characteristically involves several deregulated cellular events that are responsible for the altered innate and adaptive immune responses which significantly impact the structural alterations observed in articular cartilage and subchondral bone in this disease [49,50]. Swierkot et al [51] indicated that the receptor activator of nuclear factor-κB ligand (RANKL) expression, which in RA contributes to the elevated level of osteoclast differentiation, is regulated by the IL-6/soluble IL-6 receptor, the JAK2/STAT3/SOCS-3 pathway. They also showed that the calcineurin inhibitor tacrolimus inhibited RANKL expression in RA-fibroblast-like synoviocytes by suppressing STAT3.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, NF-κB has attracted more and more attention as a potential therapeutic target in the management of RA [78][79][80]. Modern pharmacological studies have proved that natural products can induce FLS apoptosis to prevent synovial hyperplasia via regulation of NF-κB pathway.…”
Section: Nf-κb Mediated Apoptotic Pathwaysmentioning
confidence: 99%